Cardiff and Vale University Health Board focussed on Age-related Macular Degeneration (AMD) to improve the pathway and facilitate discharge. The Pilot initially focused on fast tracking patients from the current pathway to the new pathway using treatment time as criteria for the move. A pilot of the new pathway started in April 2017. Plan Do Study Act (PDSA) methodology was used; this allowed for quick feedback and adjustments to be made. Consultants are now engaged in moving patients from the current pathway to the new pathway including moves to Virtual Clinic (no treatment for 6 months+); discharge (non-treatable AMD); and Treat and Extend Clinic (active, treatable AMD).